Validation of the I-UDS Neuropsychological Battery

Summary

The current project entails the validation of the Italian version of the Uniform Data Set (I-UDS) neuropsychological in patients with neurodegenerative diseases, specifically in patients with Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Specifically, the final aim is to explore the ability of the battery to differentiate the cognitive profiles of the two groups of patients.

Conditions

• Mild Cognitive Impairment
• Alzheimer Disease

Interventions

OTHER

Uniform Data Set (UDS) neuropsychological battery

Uniform Data Set (UDS) neuropsychological battery was administered to patients with Mild Cognitive Impairment (MCI) and patients with Alzheimer's Disease

Sponsors & Collaborators

• IRCCS Associazione Oasi Maria SS. ONLUS, Troina, Italy

  collaborator UNKNOWN

• IRCCS Istituto Auxologico Italiano, Milano, Italy

  collaborator UNKNOWN

• Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

  collaborator UNKNOWN

• IRCCS San Raffaele

  collaborator OTHER

• Fondazione IRCCS Santa Lucia, Roma, Italy

  collaborator UNKNOWN

• IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Milano, Italy

  collaborator UNKNOWN

• IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

  collaborator UNKNOWN

• IRCCS Don Gnocchi, Milano, Italy

  collaborator UNKNOWN

• IRCCS Ospedale Maggiore Policlinico, Milano, Italy

  collaborator UNKNOWN

• IRCCS AOU San Martino, Genova, Italy

  collaborator UNKNOWN

• IRCCS SDN, Napoli, Italy

  collaborator UNKNOWN

• IRCCS Fondazione Salvatore Maugeri, Pavia, Italy

  collaborator UNKNOWN

• IRCCS Istituto delle Scienze Neurologiche di Bologna

  collaborator OTHER

• Istituto Di Ricerche Farmacologiche Mario Negri

  collaborator OTHER

• Humanitas Research Hospital IRCCS, Rozzano-Milan

  collaborator OTHER

• IRCCS National Neurological Institute "C. Mondino" Foundation

  lead OTHER

Principal Investigators

• Stefano Cappa, MD · Dementia Research Center

Eligibility

Min Age

40 Years

Max Age

89 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-07-15

Primary Completion

2022-12-30

Completion

2022-12-30

Countries

• Italy

Study Locations